MultiCare Good Samaritan Hospital
401 15th Avenue Southeast, Puyallup, WA · Multicare · · NPI 1841231461
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inj, fosaprepitant (teva) HCPCS J1456 | not published | not published | $0.04 – $0.79 | 11 |
| Inj fosnetupitant, palonoset HCPCS J1454 | not published | not published | $255.16 – $1,818.02 | 14 |
| Inj., fremanezumab-vfrm 1 mg HCPCS J3031 | not published | not published | $3.43 – $9.45 | 3 |
| Inj, fulvestrant (fresenius) HCPCS J9394 | not published | not published | $12.55 – $121.13 | 13 |
| Inj, fulvestrant (teva) HCPCS J9393 | not published | not published | $14.21 – $81.67 | 11 |
| Inj, ganciclovir (exela) HCPCS J1574 | not published | not published | $71.40 – $367.71 | 2 |
| Inj gemcitabine hcl (accord) HCPCS J9196 | not published | not published | $14.04 – $121.13 | 7 |
| Inj givosiran 0.5 mg HCPCS J0223 | not published | not published | $118.56 – $508.05 | 12 |
| Inj glofitamab gxbm, 2.5 mg HCPCS J9286 | not published | not published | $2,783.86 – $12,183.29 | 13 |
| Inj glycopyrrolate fres kabi HCPCS J1598 | not published | not published | $2.83 – $4.16 | 3 |
| Inj glycopyrrolate, glyrx-pf HCPCS J1597 | $15.42 | $38.53 | not published | 0 |
| Inj golodirsen 10 mg HCPCS J1429 | not published | not published | $265.92 – $769.69 | 3 |
| Inj, granisetron, xr, 0.1 mg HCPCS J1627 | not published | not published | $3.80 – $27.32 | 11 |
| Inj., guselkumab, 1 mg HCPCS J1628 | not published | not published | $66.46 – $7,001.18 | 14 |
| Inj., haegarda 10 units HCPCS J0599 | not published | not published | $16.62 – $85.58 | 5 |
| Inj, hemgenix, per tx dose HCPCS J1411 | not published | not published | $3,617,621.00 – $8,533,000.00 | 10 |
| Inj heparin, pfizer, 1000u HCPCS J1643 | $5.92 | $14.78 | $4.10 – $8.08 | 3 |
| Inj. herceptin hylecta, 10mg HCPCS J9356 | not published | not published | $58.71 – $3,428.99 | 14 |
| Inj, hercessi, 10 mg HCPCS Q5146 | not published | not published | $37.11 – $185.34 | 10 |
| Inj herzuma 10 mg HCPCS Q5113 | not published | not published | $54.90 – $3,428.99 | 14 |
| Inj hrt cath w/s&i nonsel p-art angrp CPT 93568 | $2,232.40 | $5,581.00 | $215.00 – $232.20 | 5 |
| Inj hrt cath w/s&i sel hrt ang CPT 93563 | $3,643.60 | $9,109.00 | $215.00 – $232.20 | 5 |
| Inj hrt cath w/s&i sel hrt art CPT 93564 | $2,247.20 | $5,618.00 | $215.00 – $232.20 | 5 |
| Inj hrt cath w/s&i sel left vent CPT 93565 | $1,752.80 | $4,382.00 | $215.00 – $232.20 | 5 |
| Inj hrt cath w/s&i sel right vent CPT 93566 | $1,752.80 | $4,382.00 | $215.00 – $232.20 | 5 |
| Inj human fibrinogen con nos HCPCS J7178 | not published | not published | $1.49 – $2,018.91 | 14 |
| Inj hydroxocobalamin IV 25mg HCPCS J3424 | $7.86 | $19.65 | $5.33 – $9,511.32 | 12 |
| Inj hydroxyprogst capoat nos HCPCS J1729 | not published | not published | $14.16 – $64.17 | 8 |
| Inj., ibalizumab-uiyk, 10 mg HCPCS J1746 | not published | not published | $76.12 – $4,545.55 | 14 |
| Inj, idacio, 1 mg HCPCS Q5144 | not published | not published | $21.03 – $69.54 | 3 |
| Inj imip 4 cilas 4 releb 2mg HCPCS J0742 | not published | not published | $3.50 – $122.32 | 10 |
| Inj, imm glob bivigam, 500mg HCPCS J1556 | not published | not published | $77.85 – $328.50 | 13 |
| Inj, immphentiv, 20 mcg HCPCS J2373 | not published | not published | $0.20 – $0.35 | 3 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | not published | not published | $485.63 – $2,143.09 | 11 |
| Inj/inf neurolyt sbst spinal canal lesion 62282 CPT 62282 | $2,526.00 | $6,315.00 | $607.22 – $4,245.66 | 15 |
| Inj. infugem, 100 mg HCPCS J9198 | not published | not published | $43.66 – $279.46 | 8 |
| Inj intralesional <= 7 lsn(s) CPT 11900 | $526.40 | $1,316.00 | $116.08 – $963.09 | 15 |
| Inj intralesional > 7 lsns CPT 11901 | not published | not published | $116.08 – $963.09 | 14 |
| Inj, invega hafyera/trinza HCPCS J2427 | not published | not published | $12.69 – $7,001.18 | 13 |
| Inj ivig privigen 500 mg HCPCS J1459 | not published | not published | $48.54 – $1,272.76 | 14 |
| Inj, ixinity, 1 i.u HCPCS J7213 | not published | not published | $1.93 – $4,545.55 | 13 |
| Inj. jivi 1 iu HCPCS J7208 | not published | not published | $2.60 – $4,545.55 | 14 |
| Inj, kovaltry, 1 i.u HCPCS J7211 | not published | not published | $1.53 – $4,545.55 | 13 |
| Inj labetalol hcl hikma, 5mg HCPCS J1921 | not published | not published | $4.09 – $12.59 | 2 |
| Inj., lanadelumab-flyo, 1 mg HCPCS J0593 | not published | not published | $85.11 – $404.11 | 12 |
| Inj, lanreotide, (cipla) 1mg HCPCS J1932 | not published | not published | $31.55 – $4,545.55 | 13 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | not published | not published | $1.31 – $2.62 | 10 |
| Inj lefamulin 1 mg HCPCS J0691 | not published | not published | $1.16 – $3.33 | 3 |
| Inj, lenacapavir, 1 mg HCPCS J1961 | not published | not published | $21.85 – $4,545.55 | 13 |
| Inj levocarnitine per 1 gm HCPCS J1955 | not published | not published | $48.35 – $88.45 | 2 |
| Inj levoleucovorin nos 0.5mg HCPCS J0641 | not published | not published | $0.43 – $121.13 | 8 |
| Inj, levothyroxine, freskabi HCPCS J0651 | $20.54 | $51.34 | $3.19 – $64.17 | 14 |
| Inj, levothyroxine, hikma HCPCS J0652 | not published | not published | $7.20 – $64.17 | 9 |
| Inj, lidocaine w epinephrine HCPCS J2004 | $3.06 | $7.63 | not published | 0 |
| Inj, linezolid (hospira) HCPCS J2021 | not published | not published | $32.10 – $63.62 | 2 |
| Inj, lovotibeglogene autotem HCPCS J3394 | not published | not published | $3,180,473.76 – $7,557,800.00 | 10 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $321.16 – $1,438.87 | 11 |
| Inj., lumoxiti, 0.01 mg HCPCS J9313 | not published | not published | $22.93 – $4,545.55 | 14 |
| Inj luxturna 1 billion vec g HCPCS J3398 | not published | not published | $3,008.69 – $13,546.22 | 12 |
| Inj lwr xtr fscl pln blk uni w/wo image CPT 64473 | not published | not published | $309.03 – $333.75 | 5 |
| Inj marstacim-hncq, 0.5 mg HCPCS J7172 | not published | not published | $49.19 – $234.79 | 10 |
| Inj. meloxicam 1 mg HCPCS J1738 | not published | not published | $7.14 – $64.17 | 7 |
| Inj melpha hydroch nos 50 mg HCPCS J9245 | not published | not published | $118.25 – $4,545.55 | 14 |
| Inj, melphalan (apotex) 1 mg HCPCS J9249 | not published | not published | $63.48 – $618.68 | 12 |
| Inj, melphalan flufenami 1mg HCPCS J9247 | not published | not published | $805.60 – $3,493.24 | 3 |
| Inj melphalan (hepzato) 1 mg HCPCS J9248 | not published | not published | $779.10 – $3,210.91 | 11 |
| Inj mepivacaine hcl/10 ml HCPCS J0670 | $34.00 | $85.00 | not published | 0 |
| Inj, meropenem (b. braun) HCPCS J2184 | not published | not published | $3.38 – $9.72 | 2 |
| Inj., meropenem, vaborbactam HCPCS J2186 | not published | not published | $2.13 – $122.32 | 14 |
| Inj meropenem (wg crit care) HCPCS J2183 | not published | not published | $2.31 – $3.72 | 3 |
| Inj metaraminol bitartrate HCPCS J0380 | not published | not published | $8.22 – $8.22 | 1 |
| Inj, micafungin (par pharm) HCPCS J2247 | $0.81 | $2.01 | $0.54 – $1.85 | 4 |
| Inj, mirikizumab-mrkz, 1 mg HCPCS J2267 | not published | not published | $41.25 – $4,545.55 | 13 |
| Inj mogamulizumab-kpkc, 1 mg HCPCS J9204 | not published | not published | $248.40 – $4,545.55 | 14 |
| Inj, motixafortide, 0.25 mg HCPCS J2277 | not published | not published | $25.95 – $4,545.55 | 13 |
| Inj moxifloxacin (fres kabi) HCPCS J2281 | not published | not published | $9.29 – $24.63 | 2 |
| Inj multihance HCPCS A9577 | $8.00 | $20.00 | not published | 0 |
| Inj multihance multipack HCPCS A9578 | $8.00 | $20.00 | not published | 0 |
| Inj. mycophenolate mofetil HCPCS J7519 | not published | not published | $1.19 – $404.48 | 7 |
| Inj. naxitamab-gqgk, 1 mg HCPCS J9348 | not published | not published | $672.37 – $14,171.81 | 13 |
| Inj nephrosto/ureterogram w/img exstng access CPT 50431 | $374.40 | $936.00 | $269.75 – $3,347.17 | 15 |
| Inj, nithiodote, 3mg / 125mg HCPCS J0211 | not published | not published | $2.12 – $10.05 | 11 |
| Inj nivolumab 2 mg hyaluron HCPCS J9289 | not published | not published | $27.17 – $123.81 | 10 |
| Inj, nogapendekin pmln, 1mcg HCPCS J9028 | not published | not published | $92.71 – $14,171.81 | 13 |
| Inj non-compmd foam sclrsnt mlt trncl veins same leg CPT 36466 | not published | not published | $401.84 – $9,904.20 | 14 |
| Inj non-compmd foam sclrsnt sgl trncl vein CPT 36465 | not published | not published | $401.84 – $9,904.20 | 14 |
| Inj, nyposi 1 mcg HCPCS Q5148 | not published | not published | $1.00 – $2.50 | 10 |
| Inj ocrelizumab 1mg hya-ocsq HCPCS J2351 | not published | not published | $45.86 – $209.23 | 10 |
| Inj, ocriplasmin, 0.125 mg HCPCS J7316 | not published | not published | $430.68 – $3,428.99 | 7 |
| Inj ogivri 10 mg HCPCS Q5114 | not published | not published | $35.07 – $167.65 | 12 |
| Inj, olaratumab, 10 mg HCPCS J9285 | not published | not published | $72.90 – $4,545.55 | 8 |
| Inj, oliceridine 0.1 mg HCPCS C9101 | not published | not published | $0.62 – $1.85 | 3 |
| Inj olipudase alfa-rpcp 1mg HCPCS J0218 | not published | not published | $387.69 – $1,752.59 | 11 |
| Inj, omacetaxine mep, 0.01mg HCPCS J9262 | not published | not published | $5.53 – $796.31 | 9 |
| Inj., omadacycline, 1 mg HCPCS J0121 | not published | not published | $4.05 – $1,272.76 | 14 |
| Inj onase abepar-xioi treat HCPCS J3399 | not published | not published | $2,535,345.51 – $5,772,272.76 | 11 |
| Inj ontruzant 10 mg HCPCS Q5112 | not published | not published | $29.21 – $3,428.99 | 14 |
| Inj, palonosetron (posfrea) HCPCS J2468 | not published | not published | $54.18 – $137.40 | 10 |
| Inj pantoprazole(hikma) 40mg HCPCS J2471 | $34.76 | $86.90 | not published | 0 |
| Inj, panzyga, 500 mg HCPCS J1576 | not published | not published | $72.35 – $7,001.18 | 13 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.